| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $26.5M | — | +25.0% |
| Cost of Revenue | $8.2M | — | +5.1% |
| Gross Profit | $18.3M | — | +36.7% |
| R&D Expense | $9.5M | — | -3.9% |
| SG&A Expense | $10.8M | — | +12.7% |
| Operating Income | -$13.9M | — | +24.9% |
| Pre-tax Income | -$12.7M | — | +9.2% |
| Income Tax | $0 | — | -100.0% |
| Net Income | -$12.7M | — | +9.2% |
| EPS (Basic) | -$0.05 | — | +16.7% |
| EPS (Diluted) | -$0.05 | — | +16.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $138.0M | -8.3% | -11.1% |
| Accounts Receivable | $25.2M | -5.7% | +26.8% |
| Inventory | $59.3M | -3.4% | -14.4% |
| Current Assets | $239.8M | -3.7% | -6.8% |
| Total Assets | $285.9M | -3.6% | -10.2% |
| Current Liabilities | $59.6M | -8.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$13.9M | — | -19.0% |
| Capital Expenditures | $950K | — | +169.1% |
| Investing Cash Flow | -$950K | — | -169.1% |
| Financing Cash Flow | $2.3M | — | -97.1% |
| Free Cash Flow | -$14.8M | — | -23.4% |
| +40.3% |
| Total Liabilities | $94.7M | -5.8% | +20.3% |
| Stockholders' Equity | $191.2M | -2.4% | -20.2% |